Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichiro Ito

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Gastroenterology|March 3, 2016
Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance studyShuichi Kaneko, Kenji Ikeda, Yasushi Matsuzaki, et al.
Japanese Journal of Infectious Diseases|January 31, 2024
Proton-Pump Inhibitors and Risk of Bloodstream Infection without an Identifiable Source: a Hospital-Based Case-Control StudyShintaro Hayashi, Tomohito Moriyama, Yuichiro Ito, et al.
Investigational New Drugs|April 5, 2013
Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokineticsYu Sunakawa, Junji Furuse, Takuji Okusaka, et al.
Journal of Gastroenterology|April 24, 2016
Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEONMasatoshi Kudo, Masafumi Ikeda, Tadatoshi Takayama, et al.
Cancer Science|May 25, 2022
Real-world outcomes of pembrolizumab monotherapy in non-small cell lung cancer in Japan: A post-marketing surveillanceNobuyuki Yamamoto, Tetsu Kamitani, Kingo Kanda, et al.
The Journal of Biological Chemistry|December 24, 2002
Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1Ryoichi X Ioka, Man-Jong Kang, Shin Kamiyama, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Gastroenterology|March 3, 2016
Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance studyShuichi Kaneko, Kenji Ikeda, Yasushi Matsuzaki, et al.
Japanese Journal of Infectious Diseases|January 31, 2024
Proton-Pump Inhibitors and Risk of Bloodstream Infection without an Identifiable Source: a Hospital-Based Case-Control StudyShintaro Hayashi, Tomohito Moriyama, Yuichiro Ito, et al.
Investigational New Drugs|April 5, 2013
Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokineticsYu Sunakawa, Junji Furuse, Takuji Okusaka, et al.
Journal of Gastroenterology|April 24, 2016
Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEONMasatoshi Kudo, Masafumi Ikeda, Tadatoshi Takayama, et al.
Cancer Science|May 25, 2022
Real-world outcomes of pembrolizumab monotherapy in non-small cell lung cancer in Japan: A post-marketing surveillanceNobuyuki Yamamoto, Tetsu Kamitani, Kingo Kanda, et al.
The Journal of Biological Chemistry|December 24, 2002
Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1Ryoichi X Ioka, Man-Jong Kang, Shin Kamiyama, et al.
Pageof 4